Spain increases AstraZeneca dose gap to 16 weeks as it diverges from EU regulator advice

SourceThe National
CountrySaudi Arabia

Spain is extending the gap between the first and second doses of AstraZeneca’s Covid-19 vaccine to 16 weeks for people aged under 60, the government said on Friday.

The country is the first to promote “off-label use” and to diverge from the European Medicines Agency’s (EMA) usage authorisation.

The move is not approved by the regulator and it would make Spain responsible for any possible side effects.

The country initially gave AstraZeneca shots to essential workers aged 18 to 65 before allowing only those over the age of 60 to received the vaccine due to concerns about blood clots in younger people.

The more...